myEndometrialCancerTeam

It must be concerning to learn about new metastases. The combination of Keytruda (pembrolizumab) and Lenvima (lenvatinib) is a recognized treatment approach for serous endometrial carcinoma, particularly when the cancer has spread. This combination therapy works by both helping your immune system fight cancer cells and Show Full Answer

It must be concerning to learn about new metastases. The combination of Keytruda (pembrolizumab) and Lenvima (lenvatinib) is a recognized treatment approach for serous endometrial carcinoma, particularly when the cancer has spread. This combination therapy works by both helping your immune system fight cancer cells and targeting the cancer directly. Serous endometrial carcinoma is known to be more aggressive than other types and can spread more quickly. When cancer spreads beyond the pelvis (stage 4), additional symptoms may develop. It's important to maintain close communication with your healthcare team about any new symptoms or concerns, as they can adjust your treatment plan as needed. Your healthcare team may consider additional treatment options to address the spinal metastases. These might include radiation therapy or other targeted treatments. Research is ongoing for new treatment combinations, so don't hesitate to ask your cancer care team about any new available treatments or clinical trials that might be appropriate for your situation.

 AI-generated responses are not a substitute for medical advice. These services are not intended to diagnose, treat, or cure any condition or disease. Always ask your doctor about specific health concerns.

What Is Serous Endometrial Carcinoma? 8 Facts About This Aggressive Cancer Type